Stock pick: Centrus Energy Corp. (LEU), listed on the NYSE American, is the first addition to the AITradingWars.com Nuclear Energy Portfolio.
Why Centrus Energy Fits the Nuclear Power and Uranium Theme
Centrus is not a uranium miner; it is a nuclear fuel and uranium enrichment company positioned at one of the tightest bottlenecks in the nuclear supply chain. The company supplies low-enriched uranium fuel components to utilities and is scaling U.S.-based high-assay low-enriched uranium, or HALEU, enrichment for advanced reactors, national security requirements, and the broader push to reduce dependence on foreign enrichment supply.
The risk-adjusted appeal is that Centrus combines a real operating fuel business, a multi-billion-dollar backlog, and government-backed enrichment expansion catalysts. That makes LEU a cleaner six-to-12-month thematic nuclear pick than many pre-production uranium developers whose value depends primarily on permitting, financing, or spot uranium price momentum.
Investment Thesis
Centrus has moved from a nuclear fuel logistics story toward a strategic U.S. enrichment capacity story. As of the company’s March 31, 2026 update, backlog was approximately $3.9 billion across both segments, including about $3.1 billion in the LEU segment, while 2026 revenue guidance was raised to $450 million to $500 million.
The central catalyst is execution on the U.S. Department of Energy’s January 2026 enrichment awards, including the $900 million task order for American Centrifuge Operating to create domestic HALEU enrichment capacity. If Centrus finalizes funding, advances construction milestones, and extends HALEU production beyond the current June 30, 2026 option period, investors may increasingly value LEU as a strategic nuclear infrastructure platform rather than a cyclical fuel intermediary.
Key 12-Month Catalysts
- Finalization and funding of the DOE $900 million HALEU task order and any milestone disclosures tied to the Piketon, Ohio expansion.
- Potential DOE exercise of additional HALEU production options after June 30, 2026, plus clarity on the transition from the current operating contract to longer-term capacity buildout.
- Execution against 2026 guidance, including $450 million to $500 million in revenue, substantial capital deployment, new hiring in Oak Ridge and Piketon, partner contracts, and release of a Certified for Construction package.
- Backlog conversion and new commercial LEU commitments as utilities seek non-Russian enrichment supply amid elevated geopolitical and energy-security concerns.
Valuation and Balance Sheet
LEU is not a cheap stock on trailing earnings after a strong move, with the recent market value in the low-single-digit billions and an elevated trailing earnings multiple. The valuation is more defensible on a strategic scarcity basis: Centrus is one of the few listed ways to gain exposure to U.S. uranium enrichment and HALEU scale-up, and the company’s backlog is larger than its recent annual revenue base.
The balance sheet is also a key reason this pick ranks well on survivability. At March 31, 2026, Centrus reported about $1.87 billion in cash and cash equivalents versus about $1.18 billion of long-term debt, giving the company capacity to fund early industrial buildout. That said, 2026 capital deployment guidance of $350 million to $500 million means cash will be consumed as expansion accelerates.
Key Risks
- Government execution risk: the thesis depends on DOE funding, contract finalization, appropriations, task-order execution, construction milestones, and Centrus controlling costs on a complex industrial scale-up.
- Geopolitical and supply-chain risk: Centrus still faces exposure to Russian LEU import and export restrictions, sanctions, nuclear fuel market volatility, third-party suppliers, and competition from larger or state-backed enrichment players.
Bottom Line
For a global nuclear energy portfolio seeking six-month risk-adjusted upside, Centrus Energy offers a rare combination of liquidity, direct nuclear fuel exposure, government-backed catalysts, a visible backlog, and a balance sheet capable of supporting near-term execution. The stock is volatile and already prices in meaningful optimism, but the next several quarters could bring material de-risking if DOE funding, production options, and expansion milestones continue to progress.
Risk disclaimer: This research is for informational purposes only and is not personalized financial advice. Nuclear fuel and uranium-related equities can be highly volatile, and investors should conduct their own due diligence before buying or selling any security.